NEXGEL, Inc. (NXGL) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

NEXGEL, Inc. (NXGL) closed at USD 5.46 on 2026-10-14, a change of -89.3 % over the past year, with a market capitalization of USD 2.52M.

NEXGEL, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

NEXGEL, Inc. key figures

Previous close

USD 5.46 (2026-10-14)

1-year change

-89.3 %

Market cap

USD 2.52M

Enterprise value

USD 10.01M

P/E ratio (trailing)

-0.27

P/E ratio (forward)

-1.18

EPS (trailing)

-19.55

EPS (forward)

-4.40

PEG ratio

n/a

Price to book

0.51

Revenue growth

27.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.77

Employees

19

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for NEXGEL, Inc. and compare it with other stocks.